Mei Luo Selected Research

Mei Luo Research Topics

Disease

29	Neoplasms (Cancer) 11/2023 - 12/2013
11	Inflammation (Inflammations) 10/2023 - 01/2016
8	Infections 03/2023 - 05/2015
6	COVID-19 03/2023 - 01/2020
6	Insulin Resistance 01/2021 - 03/2011
5	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2023 - 03/2020
4	Dysbiosis 07/2023 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2016
4	Endotoxemia 10/2020 - 01/2016
4	Esophageal Squamous Cell Carcinoma 01/2018 - 11/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2018
3	Diarrhea 01/2022 - 03/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2020
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015 - 12/2013
2	Constipation 10/2023 - 07/2023
2	Leukemia 01/2023 - 01/2018
2	Systemic Scleroderma (Systemic Sclerosis) 08/2021 - 06/2020
2	Papillomavirus Infections 09/2020 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2016
2	Glioma (Gliomas) 01/2019 - 01/2018
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 09/2018
2	Fibrosis (Cirrhosis) 01/2018 - 04/2017
2	Fatty Liver 01/2017 - 01/2016
2	Obesity 01/2017 - 01/2016
2	Cognitive Dysfunction 10/2015 - 01/2015
2	Brain Ischemia (Cerebral Ischemia) 12/2012 - 10/2012
1	Acromegaly 03/2024
1	Intraoperative Complications 12/2023
1	Bronchopulmonary Dysplasia 12/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2023
1	Osteoarthritis 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Carcinogenesis 12/2022
1	Hyperlipidemias (Hyperlipidemia) 10/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2017
6	MicroRNAs (MicroRNA)IBA 01/2020 - 03/2015
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 11/2017
5	Transcription Factors (Transcription Factor)IBA 07/2023 - 09/2018
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2013
4	Messenger RNA (mRNA)IBA 10/2023 - 12/2016
4	DefensinsIBA 01/2023 - 01/2016
4	Vitamin D FDA LinkGeneric 01/2023 - 01/2016
3	LigandsIBA 03/2024 - 12/2013
3	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2016
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023 - 01/2018
3	Long Noncoding RNAIBA 01/2023 - 11/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2016
3	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 04/2017
3	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2018
3	Insulin (Novolin)FDA Link 01/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2014
2	Rifaximin (L 105)FDA Link 10/2023 - 06/2020
2	Serotonin (5 Hydroxytryptamine)IBA 10/2023 - 01/2021
2	Bile Acids and Salts (Bile Acids)IBA 07/2023 - 01/2022
2	Extracellular Matrix ProteinsIBA 01/2023 - 10/2012
2	EnzymesIBA 01/2023 - 01/2015
2	LipidsIBA 10/2022 - 01/2021
2	Therapeutic UsesIBA 01/2022 - 12/2016
2	Volatile Fatty AcidsIBA 01/2021 - 03/2020
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 03/2020
2	AntigensIBA 01/2021 - 12/2013
2	alpha-DefensinsIBA 10/2020 - 01/2016
2	EndotoxinsIBA 10/2020 - 01/2017
2	Cholestyramine Resin (Questran)FDA LinkGeneric 10/2020 - 01/2017
2	ChlorophyllIBA 09/2020 - 01/2018
2	5-hydroxymethylcytosineIBA 01/2017 - 01/2016
2	pigment epithelium-derived factorIBA 03/2014 - 03/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023
1	ProteomeIBA 11/2023
1	NeuropeptidesIBA 10/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2023
1	Loperamide (Imodium)FDA LinkGeneric 10/2023
1	Ligases (Synthetase)IBA 10/2023
1	mosaprideIBA 07/2023
1	TabletsIBA 07/2023
1	Volatile Organic CompoundsIBA 03/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Vitamin D3 24-HydroxylaseIBA 01/2023
1	Hempa (Hexamethylphosphoramide)IBA 01/2023
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	CyclinsIBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2022
1	Low Density Lipoprotein Receptor-Related Protein-5IBA 12/2022

Therapy/Procedure

19	Therapeutics 10/2023 - 10/2014
4	Immunotherapy 09/2023 - 04/2020
4	Oral Administration 01/2021 - 01/2016
2	Intraperitoneal Injections 10/2020 - 01/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 12/2016
2	Artificial Respiration (Mechanical Ventilation) 03/2018 - 11/2017
2	Parenteral Nutrition 03/2018 - 11/2017
2	Central Venous Catheters 03/2018 - 11/2017
2	Length of Stay 03/2018 - 11/2017
2	Ischemic Postconditioning 12/2014 - 10/2012
1	Patient Readmission 12/2023